The government on Monday said modified prices of 1,364 anti-cancer drug formulations have come into effect, with consumers expected to save an estimated Rs 3,540.38 crore annually following a cap on trade margins for 137 anti-cancer drugs.

The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has capped trade margins on the maximum retail price (MRP) of 137 anti-cancer drugs based on recommendations of an expert committee constituted by the Directorate General of Health Services on October 17, 2026.